Synergistic inhibition of human gastric carcinoma cell growth by 1-beta-D-arabinofuranosylcytosine and hydroxyurea or 2'-deoxyguanosine in vitro

Cancer Lett. 1992 Apr 30;63(3):221-8. doi: 10.1016/0304-3835(92)90264-v.

Abstract

The cytotoxicity of 1-beta-D-arabinofuranosylcytosine (ara-C) in combination with hydroxyurea (HU) or 2'-deoxyguanosine (GdR) on human gastric carcinoma MK-1 cells and colon carcinoma HT-15 cells was studied. Synergistic interaction between ara-C and HU on MK-1 cells and HT-15 cells, or ara-C and GdR on MK-1 cells was shown using the combination index method. HU increased the accumulation of ara-C triphosphate (ara-CTP) in the acid-soluble pool and diminished the cellular deoxyCTP (dCTP) pool. HU had no effect on the incorporation of ara-C into DNA and RNA. These results indicate that HU-induced elevation in ara-CTP and decrease in dCTP are the basis for synergy among ara-C and HU in MK-1 cells. GdR diminished cellular dCTP slightly, but it decreased the accumulation of ara-CTP in the acid-soluble pool and did not increase the incorporation of ara-C into DNA. On the other hand, ara-C increased cellular deoxyGTP (dGTP) level in the presence of GdR. These results indicate that synergy between ara-C and GdR is mediated through increased cellular dGTP which might inhibit DNA synthesis directly.

MeSH terms

  • Carcinoma / pathology
  • Cell Death / drug effects
  • Cell Division / drug effects
  • Colonic Neoplasms / pathology
  • Cytarabine / administration & dosage*
  • Deoxyguanosine / administration & dosage*
  • Deoxyribonucleotides / metabolism
  • Drug Synergism
  • Humans
  • Hydroxyurea / administration & dosage*
  • In Vitro Techniques
  • Stomach Neoplasms / pathology
  • Tumor Cells, Cultured / drug effects*

Substances

  • Deoxyribonucleotides
  • Cytarabine
  • Deoxyguanosine
  • Hydroxyurea